A new Medicare program is making select GLP-1 weight loss drugs more affordable for eligible patients, with costs as low as ...

Medicare's new GLP-1 Bridge program offers weight-loss drugs for $50 a month, but the copay sidesteps Part D's cap and Extra ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out if you qualify.

The top weight-loss drug manufacturers are promoting the new Medicare GLP-1 Bridge as the Trump administration takes a ...

For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

Millions of Medicare beneficiaries can now access GLP-1 weight loss medication with a co-pay of $50 a month through the new Medicare GLP-1 Bridge Program. The temporary federal demonstration program ...

A look at what the Medicare GLP-1 Bridge Program covers, what it doesn't, and what plan sponsors need to know.

Some adults in the Coachella Valley may qualify for GLP-1 weight loss drugs through a recently launched Medicare program. Medicare launched a temporary GLP-1 Bridge Program on July 1, which allows ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.

GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications for a $50 copay, starting July 1, 2026.

Add Yahoo as a preferred source to see more of our stories on Google. Participants in the Medicare GLP-1 Bridge program will be able to receive a GLP-1 — Foundayo, Zepbound or Wegovy (above) — at a ...